AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sitaglo MSR Forte Tablet PR

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitaglo MSR Forte Tablet PR

Sitaglo MSR Forte Tablet PR combines two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lessening the risk of cardiovascular events like stroke or heart attack. Sitaglo MSR Forte may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and consistent physical activity. Dosage is personalized, considering your health status, glucose readings, and existing medications. Consuming it with meals minimizes gastrointestinal discomfort. For maximum efficacy, adhere to a consistent daily dosing schedule and avoid discontinuation without your physician's guidance. Maintaining the prescribed diet and exercise regimen is crucial for diabetes management. Common side effects include nausea, diarrhea, vomiting, stomach upset, headache, and throat irritation. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, requires awareness and appropriate management. This medication is not universally suitable. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions necessitate disclosing all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sitaglo MSR Forte Tablet PR

Managing type 2 diabetes

Major Benefits of Sitaglo MSR Forte Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Ingest Sitaglo MSR Forte Tablet PR with a meal.

Common Side effects of Sitaglo MSR Forte Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglo MSR Forte Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. Administer Sitaglo MSR Forte Tablet PR with food.

How Sitaglo MSR Forte Tablet PR works:

Sitaglo MSR Forte Tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, improves the body's insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action facilitates superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitaglo MSR Forte Tablet PR is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Sitaglo MSR Forte Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Sitaglo MSR Forte Tablet PR while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaglo MSR Forte Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitaglo MSR Forte Tablet PR is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitaglo MSR Forte Tablet PR :

Should you forget a dose of Sitaglo MSR Forte Tablet PR, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Sitaglo MSR Forte Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Sitaglo MSR Forte Tablet PR

Sitaglo MSR Forte Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and increases insulin sensitivity. Sitagliptin blocks DPP-4, boosting pancreatic insulin release. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitaglo MSR Forte Tablet PR can indeed lead to vitamin B12 deficiency. This medication impedes the stomach's absorption of vitamin B12. Consequently, untreated deficiency may result in anemia and neurological complications, manifesting as numbness and tingling in extremities, muscular weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Sitaglo MSR Forte Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse events include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo MSR Forte Tablet PR ingredient or inactive component should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitaglo MSR Forte Tablets is unsafe due to a heightened risk of lactic acidosis.
Maintain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition stemming from excessive blood lactic acid, is a potential side effect of Sitaglo MSR Forte Tablet PR. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Consequently, its use is contraindicated in individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Characteristic symptoms encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin immediately and seek professional medical attention.
Sitaglo MSR Forte Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin blocks the DPP4 enzyme, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Taking Sitaglo MSR Forte Tablet PR may cause frequent side effects such as low blood sugar (hypoglycemia), changes in taste perception, queasiness, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rarely, but seriously, lactic acidosis may occur. Prolonged use can also result in a deficiency of vitamin B12.
Patients with hypersensitivity to any Sitaglo MSR Forte Tablet PR ingredient or inactive component should not use this medication. Its use is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo MSR Forte Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential complication of Sitaglo MSR Forte Tablet PR. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but necessitates caution. Its occurrence is minimized by avoiding metformin use in individuals with renal impairment, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia may indicate lactic acidosis. If such symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged consumption of Sitaglo MSR Forte Tablet PR can indeed lead to Vitamin B12 deficiency. This medication impairs the body's ability to absorb Vitamin B12 from the gastrointestinal tract. Consequently, untreated deficiency may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Maintain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitaglo MSR Forte Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and regular physical activity. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin works by blocking DPP4, thus boosting pancreatic insulin release. This formulation is unsuitable for individuals under 18.
Taking Sitaglo MSR Forte Tablet PR may result in common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects include lactic acidosis. Prolonged use can also cause vitamin B12 deficiency.
Patients with hypersensitivity to Sitaglo MSR Forte Tablet PR constituents or inactive ingredients should not use this medication. Similarly, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo MSR Forte Tablet PR and alcohol is unsafe due to the heightened risk of lactic acidosis.
Sitagliptin/Metformin combination tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in patients with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Symptoms may present as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitaglo MSR Forte Tablet PR administration can indeed lead to vitamin B12 deficiency. This medication impairs the stomach's absorption of vitamin B12. Consequently, untreated deficiency may manifest as anemia, neurological complications including paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Retain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Sitaglo MSR Forte Tablet ...
180
MRP 209
13% off